About One-Third With Cancer Have Had Previous Major Adverse Financial Event
By Elana Gotkine HealthDay Reporter
THURSDAY, Feb. 8, 2024 -- About one-third of patients newly diagnosed with cancer reported having a major adverse financial event (AFE) before diagnosis, and those with previous AFEs are more likely to be diagnosed with later-stage cancer, according to a study published online Feb. 6 in the Journal of Clinical Oncology.
Joan L. Warren, Ph.D., from the National Cancer Institute in Bethesda, Maryland, and colleagues identified patients aged 20 to 69 years diagnosed with cancer during 2014 to 2015 from the Seattle, Louisiana, and Georgia Surveillance, Epidemiology, and End Results population-based cancer registries. The association of AFEs with later-stage cancer diagnoses (stages III/IV) was examined in sex-specific analyses.
The researchers identified 101,649 patients with cancer, of whom 36.2 percent had a major AFE reported before diagnosis. The mean and median AFE closest to diagnosis was 93 and 77 months, respectively. Non-Hispanic Black, unmarried, and low-income patients most often had AFEs. Compared with those with no AFE, individuals with previous AFEs were more likely to be diagnosed with later-stage cancer (odds ratios, 1.09 and 1.18 for men and women, respectively) after adjustment for age, race, marital status, income, registry, and cancer type. There was no variation seen in the associations between AFEs prediagnosis and later-stage disease by AFE timing.
"Our findings raise substantial concerns for the outcomes for people with an AFE before cancer diagnosis who are among the most vulnerable of all patients with cancer," the authors write.
One author disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted February 2024
Read this next
Mortality in Rheumatic Heart Disease Is High
FRIDAY, June 7, 2024 -- Mortality related to rheumatic heart disease (RHD) is high and is correlated with the severity of valve disease, according to a study published online June...
Higher County-Level Prostate Cancer Screening Tied to Better Outcomes
FRIDAY, June 7, 2024 -- Higher county-level prevalence of prostate-specific antigen (PSA) screening is associated with lower odds of advanced disease, all-cause mortality, and...
Metabolic Impact on Offspring Similar for Frozen, Fresh Embryo Transfer
FRIDAY, June 7, 2024 -- For glucose and lipid profiles during early childhood, the impact of frozen embryo transfer (FET) is comparable to that of fresh embryo transfer, according...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.